Research Article

The Value of Pituitary Irradiation in the Treatment of Hypersomatotropinism, Criteria Useful for Monitoring Treatment Outcomes, and Patient Selection for Cobalt Therapy

Volume: 27 Number: 3-4 December 30, 1974
Selahattin Koloğlu *
TR EN

The Value of Pituitary Irradiation in the Treatment of Hypersomatotropinism, Criteria Useful for Monitoring Treatment Outcomes, and Patient Selection for Cobalt Therapy

Abstract

The results of treatment were evaluated using static and dynamic studies of somatotropin (STR) secretion in 40 cases of acromegaly and gigantism treated with pituitary gamma teleradiotherapy. Treatment with pituitary cobalt therapy yielded favorable results in 6.57 to 65.0% of cases. Complete success was demonstrated by the return to normal baseline STH levels and the disappearance of autonomy, replaced by normal dynamic responses. The effects of the treatment began after 6 months, but STH secretion normalized after 2 years. No significant complications were observed with this treatment. While the results obtained with other methods used in the treatment of hypersomatotropinism are somewhat better, the fact that the side effects observed with these methods are not observed with photontherapy should be considered sufficient to compensate for this difference. Phototherapy should continue to be used as the initial treatment for pituitary lesions that do not exhibit compression or extrasellar development. Cobalt therapy has a slow onset of action; except in cases where the etiological lesion continues to undergo biological or anatomical evolution, a new treatment modality should not be implemented within two years of treatment, and the patient should be kept under observation.

Keywords

acromegaly, pituitary irradiation, somatotropin

Supporting Institution

Ankara University Faculty of Medicine, Department of Endocrinology and Metabolic Diseases

References

  1. 1 - Adams, J. et al.: Transphenoidal cryohypophysectomy in acromegaly. Clinical and Endocrinological evaluation. J. of Neurosurgery, 28/1:100, 1968.
  2. 2 - Aurugkin, T. W., Sau, K.: Childhood acromegaly; successful therapy with conventional radiation and effects of chlorpromazine on growth hormone and prolactin secretion. J. Clin. Endocr. and Meta., 37/3:380, 1973.
  3. 3 - Beck, P. et al.: Correlation studies of growth hormone and insulin plasma concentration with metabolic abnormalities in acromegaly. J. Lab. Clin. Med., 66:366, 1965.
  4. 4 - Bronson, A. B.: Surgical hypophysectomy as a treatment for acromegaly. Clin. Endocr., 11:93, 1968.
  5. 5 - Christy, N. P.: Pituitary radiation treatment. Hosp. Proc., 4:54, 1969.
  6. 6 - Collins, W. F.: Hypophysectomy: Historical and personal perspective. Clinical Neurosurgery, 21:68, 1974.
  7. 7 - Conway, L. W., Collins, W. F.: Results of trans-sphenoidal cryohypophysectomy for carcinoma of the breast. New Eng. J. of Med., 281:1, 1969.
  8. 8 - Correa, J. N., Lampe, I.: Radiation treatment of pituitary adenomas. J. Neurosurgery, 19:626, 1962.
  9. 9 - Cross, N. N. et al.: Treatment of acromegaly by cryosurgery. Lancet, 1:215, 1972.
  10. 10 - Cryer, P. E., Daughaday, W. H.: Studies on etiology of Acromegaly. J. Clin. Endocr., 29:386, 1969.
APA
Koloğlu, S. (1974). The Value of Pituitary Irradiation in the Treatment of Hypersomatotropinism, Criteria Useful for Monitoring Treatment Outcomes, and Patient Selection for Cobalt Therapy. Ankara Üniversitesi Tıp Fakültesi Mecmuası, 27(3-4), 757-784. https://izlik.org/JA27ZY56GM
AMA
1.Koloğlu S. The Value of Pituitary Irradiation in the Treatment of Hypersomatotropinism, Criteria Useful for Monitoring Treatment Outcomes, and Patient Selection for Cobalt Therapy. Ankara Üniversitesi Tıp Fakültesi Mecmuası. 1974;27(3-4):757-784. https://izlik.org/JA27ZY56GM
Chicago
Koloğlu, Selahattin. 1974. “The Value of Pituitary Irradiation in the Treatment of Hypersomatotropinism, Criteria Useful for Monitoring Treatment Outcomes, and Patient Selection for Cobalt Therapy”. Ankara Üniversitesi Tıp Fakültesi Mecmuası 27 (3-4): 757-84. https://izlik.org/JA27ZY56GM.
EndNote
Koloğlu S (December 1, 1974) The Value of Pituitary Irradiation in the Treatment of Hypersomatotropinism, Criteria Useful for Monitoring Treatment Outcomes, and Patient Selection for Cobalt Therapy. Ankara Üniversitesi Tıp Fakültesi Mecmuası 27 3-4 757–784.
IEEE
[1]S. Koloğlu, “The Value of Pituitary Irradiation in the Treatment of Hypersomatotropinism, Criteria Useful for Monitoring Treatment Outcomes, and Patient Selection for Cobalt Therapy”, Ankara Üniversitesi Tıp Fakültesi Mecmuası, vol. 27, no. 3-4, pp. 757–784, Dec. 1974, [Online]. Available: https://izlik.org/JA27ZY56GM
ISNAD
Koloğlu, Selahattin. “The Value of Pituitary Irradiation in the Treatment of Hypersomatotropinism, Criteria Useful for Monitoring Treatment Outcomes, and Patient Selection for Cobalt Therapy”. Ankara Üniversitesi Tıp Fakültesi Mecmuası 27/3-4 (December 1, 1974): 757-784. https://izlik.org/JA27ZY56GM.
JAMA
1.Koloğlu S. The Value of Pituitary Irradiation in the Treatment of Hypersomatotropinism, Criteria Useful for Monitoring Treatment Outcomes, and Patient Selection for Cobalt Therapy. Ankara Üniversitesi Tıp Fakültesi Mecmuası. 1974;27:757–784.
MLA
Koloğlu, Selahattin. “The Value of Pituitary Irradiation in the Treatment of Hypersomatotropinism, Criteria Useful for Monitoring Treatment Outcomes, and Patient Selection for Cobalt Therapy”. Ankara Üniversitesi Tıp Fakültesi Mecmuası, vol. 27, no. 3-4, Dec. 1974, pp. 757-84, https://izlik.org/JA27ZY56GM.
Vancouver
1.Selahattin Koloğlu. The Value of Pituitary Irradiation in the Treatment of Hypersomatotropinism, Criteria Useful for Monitoring Treatment Outcomes, and Patient Selection for Cobalt Therapy. Ankara Üniversitesi Tıp Fakültesi Mecmuası [Internet]. 1974 Dec. 1;27(3-4):757-84. Available from: https://izlik.org/JA27ZY56GM